Abstract
Purpose
Primary hyperparathyroidism has deleterious effects on health and causes nephrolithiasis and osteoporosis. However, it remains unclear whether parathyroidectomy benefits kidney function among patients with primary hyperparathyroidism.
Methods
In this retrospective study, patients with primary hyperparathyroidism receiving parathyroidectomy in a tertiary medical center between 2003 and 2017 were followed up until December 31 2017, death, or requiring renal replacement therapy. Impact of parathyroidectomy on kidney function was examined using longitudinal estimated glomerular filtration rate (eGFR) change scales: single, average, absolute difference, percent change, annual decline rate, and slope. We applied linear mixed-effect model to determine the effect of parathyroidectomy on kidney function.
Results
During study period, 167 patients with primary hyperparathyroidism were identified from 498 parathyroidectomized patients, and finally, 27 patients fulfilled our stringent criteria. Median follow-up duration was 1.50 years (interquartile range 1.05–1.81) before surgery and 2.47 years (1.37–6.43) after surgery. Although parathyroidectomy did not affect amount of proteinuria and distribution of eGFR, parathyroidectomy significantly slowed decline rate of eGFR compared with that before surgery (− 1.67 versus − 2.73 mL/min/1.73 m2/year, p < 0.001). More importantly, parathyroidectomy made more beneficial effects on kidney function in patients with age < 65 years and those without chronic kidney disease or hypertension.
Conclusions
Our study showed that parathyroidectomy slows renal function decline irrespective of age or comorbidities, which offers novel insight into the revision of guidelines for surgical indications in primary hyperparathyroidism. Given small sample size, further large-scale controlled studies are warranted to confirm our findings.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are not publicly available, but are available from the corresponding author on reasonable request.
References
Marcocci C, Cetani F (2011) Clinical practice. Primary hyperparathyroidism. N Engl J Med 365(25):2389–2397. https://doi.org/10.1056/NEJMcp1106636
Bilezikian JP, Bandeira L, Khan A, Cusano NE (2018) Hyperparathyroidism. Lancet (Lond, Engl) 391(10116):168–178. https://doi.org/10.1016/s0140-6736(17)31430-7
Liu M, Sum M, Cong E, Colon I, Bucovsky M, Williams J, Kepley A, Kuo J, Lee JA, Lazar RM, Marshall R, Silverberg S, Walker MD (2020) Cognition and cerebrovascular function in primary hyperparathyroidism before and after parathyroidectomy. J Endocrinol Invest 43(3):369–379. https://doi.org/10.1007/s40618-019-01128-0
Press DM, Siperstein AE, Berber E, Shin JJ, Metzger R, Monteiro R, Mino J, Swagel W, Mitchell JC (2013) The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 154(6):1232–1237 (discussion 1237–1238)
Wu B, Haigh PI, Hwang R, Ituarte PH, Liu IL, Hahn TJ, Yeh MW (2010) Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab 95(9):4324–4330. https://doi.org/10.1210/jc.2009-2819
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY, Doherty GM, Herrera MF, Pasieka JL, Perrier ND, Silverberg SJ, Solorzano CC, Sturgeon C, Tublin ME, Udelsman R, Carty SE (2016) The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959–968. https://doi.org/10.1001/jamasurg.2016.2310
Hendrickson CD, Castro Pereira DJ, Comi RJ (2014) Renal impairment as a surgical indication in primary hyperparathyroidism: do the data support this recommendation? J Clin Endocrinol Metab 99(8):2646–2650. https://doi.org/10.1210/jc.2014-1379
Verdelli C, Corbetta S (2017) Mechanisms in endocrinology: kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects. Eur J Endocrinol 176(1):R39–r52. https://doi.org/10.1530/eje-16-0430
Tassone F, Guarnieri A, Castellano E, Baffoni C, Attanasio R, Borretta G (2015) Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 100(8):3069–3073. https://doi.org/10.1210/jc.2015-2132
Nair CG, Babu M, Jacob P, Menon R, Mathew J, Unnikrishnan (2016) Renal dysfunction in primary hyperparathyroidism; effect of parathyroidectomy: a retrospective Cohort Study. Int J Surg (Lond, Engl) 36(Pt A):383–387. https://doi.org/10.1016/j.ijsu.2016.11.009
Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415–5422. https://doi.org/10.1210/jc.2004-0028
Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(5):1687–1692. https://doi.org/10.1210/jc.2006-1836
Kristoffersson A, Backman C, Granqvist K, Jarhult J (1990) Pre- and postoperative evaluation of renal function with five different tests in patients with primary hyperparathyroidism. J Intern Med 227(5):317–324. https://doi.org/10.1111/j.1365-2796.1990.tb00166.x
Rowlands C, Zyada A, Zouwail S, Joshi H, Stechman MJ, Scott-Coombes DM (2013) Recurrent urolithiasis following parathyroidectomy for primary hyperparathyroidism. Ann R Coll Surg Engl 95(7):523–528. https://doi.org/10.1308/003588413x13629960048712
dos Santos JHZ, Enout MJR, Shimozono AT, Fujjiz LI, de Rocha LA, Santos RO, das Neves MC (2018) Evolution of renal function in patients with primary hyperparathyroidism submitted to parathyroidectomy. Arch Head Neck Surg 47(1):e0886
Garcia-Martin F, Guadalix S, Garcia-Boyano F, Melon Pena N, Martinez Pueyo JI, Callejas Martinez R, Praga Terente M (2019) Does renal function improve after parathyroidectomy in primary hyperparathyroidism? Nefrologia 39(2):160–167. https://doi.org/10.1016/j.nefro.2018.08.007
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-y (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305
Wen CP, Cheng TYD, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH (2008) All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. The Lancet 371(9631):2173–2182
Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311(24):2518–2531. https://doi.org/10.1001/jama.2014.6634
Ragot S, Saulnier P-J, Velho G, Gand E, de Hauteclocque A, Slaoui Y, Potier L, Sosner P, Halimi J-M, Zaoui P (2016) Dynamic changes in renal function are associated with major cardiovascular events in patients with type 2 diabetes. Diabetes Care 39(7):1259–1266
Shou H, Hsu JY, Xie D, Yang W, Roy J, Anderson AH, Landis JR, Feldman HI, Parsa A, Jepson C (2017) Analytic considerations for repeated measures of eGFR in cohort studies of CKD. Clin J Am Soc Nephrol 12(8):1357–1365
Tsai CW, Huang HC, Chiang HY, Chung CW, Chiu HT, Liang CC, Yu T, Kuo CC (2019) First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease. Nephrol Dial Transplant 34(12):2066–2078. https://doi.org/10.1093/ndt/gfy200
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
Imam TH, Fischer H, Jing B, Burchette R, Henry S, DeRose SF, Coleman KJ (2017) Estimated GFR before and after bariatric surgery in CKD. Am J Kidney Dis 69(3):380–388. https://doi.org/10.1053/j.ajkd.2016.09.020
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150
Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J (2009) Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol JASN 20(12):2617–2624. https://doi.org/10.1681/asn.2009010025
Kopple JD (2001) National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 37(1 Suppl 2):S66–S70. https://doi.org/10.1053/ajkd.2001.20748
Naumova EN, Must A, Laird NM (2001) Tutorial in Biostatistics: Evaluating the impact of ‘critical periods’ in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol 30(6):1332–1341. https://doi.org/10.1093/ije/30.6.1332
Kir S, Polat C (2020) Effects of preoperative calcium levels and parathyroidectomy on renal function in primary hyperparathyroidism: a retrospective study. Croat Med J 61(1):33–39. https://doi.org/10.3325/cmj.2020.61.33
Kurts C (2013) A crystal-clear mechanism of chronic kidney disease. Kidney Int 84(5):859–861. https://doi.org/10.1038/ki.2013.251
Rashid G, Bernheim J, Green J, Benchetrit S (2007) Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 292(4):F1215–F1218. https://doi.org/10.1152/ajprenal.00406.2006
Evenepoel P, Bover J, Ureña Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90(6):1184–1190. https://doi.org/10.1016/j.kint.2016.06.041
Cardenas MG, Vigil KJ, Talpos GB, Lee MW, Peterson E, Rao DS (2008) Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism. Endocr Pract 14(1):69–75. https://doi.org/10.4158/ep.14.1.69
Rosenthal FD, Roy S (1972) Hypertension and hyperparathyroidism. BMJ 4(5837):396–397. https://doi.org/10.1136/bmj.4.5837.396
Bolland MJ, Grey AB, Gamble GD, Reid IR (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 90(3):1525–1530. https://doi.org/10.1210/jc.2004-1891
Duran C, Sevinc B, Kutlu O, Karahan O (2017) Parathyroidectomy decreases insulin resistance index in patients with primary hyperparathyroidism. Indian J Surg 79(2):101–105. https://doi.org/10.1007/s12262-015-1431-4
Udelsman R, Lin Z, Donovan P (2011) The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 253(3):585–591. https://doi.org/10.1097/SLA.0b013e318208fed9
He L, Wei Q, Liu J, Yi M, Liu Y, Liu H, Sun L, Peng Y, Liu F, Venkatachalam MA, Dong Z (2017) AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney Int 92(5):1071–1083. https://doi.org/10.1016/j.kint.2017.06.030
Almqvist EG, Becker C, Bondeson AG, Bondeson L, Svensson J (2004) Early parathyroidectomy increases bone mineral density in patients with mild primary hyperparathyroidism: a prospective and randomized study. Surgery 136(6):1281–1288. https://doi.org/10.1016/j.surg.2004.06.059
Walker MD, Nickolas T, Kepley A, Lee JA, Zhang C, McMahon DJ, Silverberg SJ (2014) Predictors of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab 99(5):1885–1892. https://doi.org/10.1210/jc.2013-4192
Funding
This study was supported in part by China Medical University Hospital (DMR-109-028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
CCL: study concept, design, and drafting of the manuscript. YCL and HCT: acquisition of data and analysis. HCY, CCK, and SPH: interpretation of data and revision of the manuscript. THY and CYC: critical revision of the manuscript for important intellectual content. CCK: study supervision.
Corresponding author
Ethics declarations
Conflict of interest
The results presented in part at the Annual Meeting of the Taiwan Society of Nephrology held 22–24 November 2019 in Taipei, Taiwan. The authors have no conflicts of interest regarding the design or publication of this study. This work will not be submitted for publication elsewhere until the editorial board has decided whether to publish the article.
Ethical approval
The study was approved by the Big Data Center of China Medical University Hospital and the Research Ethical Committee/Institutional Review Board of China Medical University Hospital (CMUH105-REC3-068).
Informed consent
The need to obtain informed consent for the present study was waived by the Research Ethical Committee of China Medical University Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Liang, CC., Yeh, HC., Lo, YC. et al. Parathyroidectomy slows renal function decline in patients with primary hyperparathyroidism. J Endocrinol Invest 44, 755–763 (2021). https://doi.org/10.1007/s40618-020-01369-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01369-4